Manufacturing Sciences, Validation Engineer Intern
AstraZeneca
Summary
We are looking for rising junior and senior students studying biosciences, mechanical engineering, chemical engineering, biochemical engineering, biotechnology or a related field for a 12-week internship role at our site in Gaithersburg, MD from May 24, 2027 to August 13, 2027.
Job description
Position Description
- Analyze validation data.
- Perform risk assessments.
- Assist with validation projects.
Requirements
- Rising junior and senior students studying biosciences, mechanical engineering, chemical engineering, biochemical engineering, biotechnology or a related field.
- Proficiency using Excel, Smartsheet, MS Teams, and Word is required.
- Ability to be self-sufficient, work independently and collaborate with cross functional teams is required.
- Experience with assessing risk and developing project timelines is beneficial.
- Exposure to data analysis using AI is preferred.
- Technical writing skills are preferred.
- Candidates must have an expected graduation date after August 2027.
- US Work Authorization is required at time of application.
- This role will not be granting CPT support.
- Ability to report onsite to Gaithersburg, MD site 5 days per week. This role will not provide relocation assistance.
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.